Insiders Updates Recent Insider Activity Could Benefit Atossa Therapeutics Inc (ATOS) Atossa Therapeutics Inc’s filing revealed that its Director Remmel H. Lawrence acquired Company’s shares for reported $7000.0 on Mar 26
Analysts Viewpoint Investing in Atossa Therapeutics Inc (ATOS): What You Must Know Atossa Therapeutics Inc’s recent filing unveils that its Director Remmel H. Lawrence acquired Company’s shares for reported $7000.0 on Mar
No Stopping Atossa Therapeutics Inc. (NASDAQ: ATOS) These Days Atossa Therapeutics Inc. (NASDAQ:ATOS) does about 563.52K shares in volume on a normal day but saw 206077 shares change hands